You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
A股異動 | 博雅生物(300294.SZ)復牌漲超7% 華潤醫藥控股將成為公司控股股東
格隆匯 10-09 14:26
格隆匯10月9日丨博雅生物(300294.SZ)今日復牌高開高走,現報43.3元,漲7.58%,暫成交7.3億元,最新總市值187億元。博雅生物9月30日晚間發公告稱,高特佳集團與華潤醫藥控股簽訂了《股份轉讓協議》、《表決權委託協議》;同時,華潤醫藥控股與博雅生物簽署了《附條件生效的向特定對象發行股份認購協議》。公司擬向華潤醫藥控股發行股票,華潤醫藥控股擬全額認購公司向其發行的8666.4972萬股股份,發行價格為31.43元/股。完成後,華潤醫藥控股將成為公司控股股東,中國華潤將成為公司實際控制人,國務院國資委將成為公司最終實際控制人。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account